Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transplant update

N Parrott

    The British Journal of Theatre Nursing : Natnews : the Official Journal of the National Association of Theatre Nurses
    |August 1, 1996
    PubMed
    Summary

    Solid organ transplantation has advanced significantly, with acute rejection no longer a primary threat to graft survival. This review covers current management strategies for acute and chronic rejection and new immunosuppressive agents.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Inhalational induction of general anaesthesia for elective caesarean: ethical acceptability in treatment-resistant needle phobia?

    International journal of obstetric anesthesia·2020
    Same author

    Quantitative systems pharmacology: a promising approach for translational pharmacology.

    Drug discovery today. Technologies·2016
    Same author

    Bottom-up Meets Top-down: Complementary Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling for Regulatory Approval of a Dosing Algorithm of Valganciclovir in Very Young Children.

    Clinical pharmacology and therapeutics·2016
    Same author

    A Physiologically Based Pharmacokinetic Model for Ganciclovir and Its Prodrug Valganciclovir in Adults and Children.

    The AAPS journal·2016
    Same author

    Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.

    Clinical pharmacology and therapeutics·2015
    Same author

    Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness.

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2013

    Area of Science:

    • Immunology
    • Transplant Surgery
    • Pharmacology

    Background:

    • Solid organ transplantation has evolved from experimental to a common clinical practice over the past two decades.
    • Historically, acute rejection was a major cause of graft loss, significantly impacting one-year graft survival rates, especially in renal transplantation.
    • Advances in medical science have transformed transplantation outcomes, making procedures like kidney, heart, and liver transplants relatively commonplace.

    Purpose of the Study:

    • To review current management strategies for acute and chronic rejection in solid organ transplantation.
    • To discuss the evolving role of novel immunosuppressive agents in preventing and treating transplant rejection.
    • To provide an overview of the progress in transplantation medicine.

    Main Methods:

    • Literature review of current research and clinical practices in solid organ transplantation.
    • Analysis of historical data on graft survival rates and causes of graft loss.
    • Examination of the mechanisms and clinical applications of new immunosuppressive agents.

    Main Results:

    • Acute rejection, once a critical barrier, is now manageable in most cases, significantly improving graft survival.
    • One-year graft survival for renal transplantation has dramatically improved from below 50% to much higher rates.
    • New immunosuppressive agents have played a crucial role in mitigating rejection episodes.

    Conclusions:

    • Solid organ transplantation has achieved remarkable success, largely due to improved management of acute rejection.
    • The development and application of new immunosuppressive drugs are central to the ongoing success of transplantation.
    • Continued research into rejection mechanisms and novel therapies will further enhance long-term graft survival and patient outcomes.

    Related Experiment Videos